Avanos Medical (AVNS) Operating Expenses (2013 - 2026)

Avanos Medical has disclosed Operating Expenses across 14 years of filings, most recently posting $82.9 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $82.9 million, up 2.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $340.7 million (up 1.64% YoY), and the FY2025 annual result was $338.9 million, down 1.68% from the prior year.
• Operating Expenses came in at $82.9 million for Q1 2026 at Avanos Medical, down from $84.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $99.8 million in Q2 2023 to a low of $81.1 million in Q1 2025.
• The 5-year median for Operating Expenses is $85.4 million (2022), against an average of $87.6 million.
• Across the five-year window, Operating Expenses grew 29.95% in 2022 and dropped 12.63% in 2024, its largest moves.
• Avanos Medical's Operating Expenses stood at $85.9 million in 2022, then declined by 5.36% to $81.3 million in 2023, then gained by 5.04% to $85.4 million in 2024, then retreated by 0.59% to $84.9 million in 2025, then dropped by 2.36% to $82.9 million in 2026.
• The last three Operating Expenses figures came in at $82.9 million (Q1 2026), $84.9 million (Q4 2025), and $83.6 million (Q3 2025), per Business Quant data.